{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:31:22Z","timestamp":1789561882024,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11357-022-00565-9","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T19:02:31Z","timestamp":1650654151000},"page":"1727-1741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis"],"prefix":"10.1007","volume":"44","author":[{"given":"Mohanraj","family":"Rajesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"B\u00e1tkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n V.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"M\u00e1ty\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janos","family":"Paloczi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lehocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Hask\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7036-8108","authenticated-orcid":false,"given":"Pal","family":"Pacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"565_CR1","doi-asserted-by":"publisher","first-page":"e014891","DOI":"10.1161\/JAHA.119.014891","volume":"9","author":"JR Ryder","year":"2020","unstructured":"Ryder JR, Northrop E, Rudser KD, Kelly AS, Gao Z, Khoury PR, Kimball TR, Dolan LM, Urbina EM. Accelerated early vascular aging among adolescents with obesity and\/or type 2 diabetes mellitus. J Am Heart Assoc. 2020;9:e014891.","journal-title":"J Am Heart Assoc"},{"key":"565_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cger.2009.09.001","volume":"25","author":"CT Cigolle","year":"2009","unstructured":"Cigolle CT, Blaum CS, Halter JB. Diabetes and cardiovascular disease prevention in older adults. Clin Geriatr Med. 2009;25:607\u201341, vii\u2013viii.","journal-title":"Clin Geriatr Med"},{"key":"565_CR3","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.2337\/dc12-1801","volume":"35","author":"MS Kirkman","year":"2012","unstructured":"Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, Pratley RE, Swift CS. Diabetes in older adults. Diabetes Care. 2012;35:2650\u201364.","journal-title":"Diabetes Care"},{"key":"565_CR4","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.2337\/dc08-s240","volume":"31","author":"Z Milicevic","year":"2008","unstructured":"Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M. Natural history of cardiovascular disease in patients with diabetes. Diabetes Care. 2008;31:S155\u201360.","journal-title":"Diabetes Care"},{"key":"565_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30:595\u2013602.","journal-title":"Am J Cardiol"},{"key":"565_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jdi.12250","volume":"5","author":"Q Liu","year":"2015","unstructured":"Liu Q, Wang S, Cai L. Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage. J Diabetes Investig. 2015;5:623\u201334.","journal-title":"J Diabetes Investig"},{"key":"565_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbadis.2014.06.030","volume":"1852","author":"ZV Varga","year":"2015","unstructured":"Varga ZV, Giricz Z, Liaudet L, Hasko G, Ferdinandy P, Pacher P. Interplay of oxidative nitrosative nitrative stress inflammation cell death and autophagy in diabetic cardiomyopathy. Biochim Biophys Acta (BBA) - Mole Basis Dis. 2015;1852:232\u201342.","journal-title":"Biochim Biophys Acta (BBA) - Mole Basis Dis"},{"key":"565_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/0929867053363207","volume":"12","author":"P Pacher","year":"2005","unstructured":"Pacher P, Obrosova IG, Mabley JG, Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications Emerging new therapeutical strategies. Curr Med Chem. 2005;12:267\u201375.","journal-title":"Curr Med Chem"},{"key":"565_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2337\/diabetes.54.1.234","volume":"54","author":"IG Obrosova","year":"2005","unstructured":"Obrosova IG, Pacher P, Szab\u00c3 C, Zsengeller Z, Hirooka H, Stevens MJ, Yorek MA. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes. 2005;54:234\u201342.","journal-title":"Diabetes"},{"key":"565_CR10","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1111\/j.1582-4934.2008.00564.x","volume":"13","author":"M Rajesh","year":"2009","unstructured":"Rajesh M, Mukhopadhyay P, B\u00e1tkai S, Mukhopadhyay B, Patel V, Hask\u00f3 G, Szab\u00f3 C, Mabley JG, Liaudet L, Pacher P. Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy. J Cell Mol Med. 2009;13:2330\u201341.","journal-title":"J Cell Mol Med"},{"key":"565_CR11","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2337\/db11-0477","volume":"61","author":"M Rajesh","year":"2012","unstructured":"Rajesh M, B\u00e1tkai S, Kechrid M, Mukhopadhyay P, Lee W-S, Horv\u00e1th B, Holovac E, Cinar R, Liaudet L, Mackie K, Hask\u00f3 G, Pacher P. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes. 2012;61:716\u201327.","journal-title":"Diabetes"},{"key":"565_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1476-5381.2012.02042.x","volume":"167","author":"S Steffens","year":"2012","unstructured":"Steffens S, Pacher P. Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies. Br J Pharmacol. 2012;167:313\u201323.","journal-title":"Br J Pharmacol"},{"key":"565_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrcardio.2017.130","volume":"15","author":"P Pacher","year":"2018","unstructured":"Pacher P, Steffens S, Hasko G, Schindler TH, Kunos G. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nat Rev Cardiol. 2018;15:151\u201366.","journal-title":"Nat Rev Cardiol"},{"key":"565_CR14","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/hep.30916","volume":"71","author":"C Matyas","year":"2020","unstructured":"Matyas C, Erdelyi K, Trojnar E, Zhao S, Varga ZV, Paloczi J, Mukhopadhyay P, Nemeth BT, Hasko G, Cinar R, Rodrigues RM, Ait Ahmed Y, Gao B, Pacher P. Interplay of liver-heart inflammatory axis and cannabinoid 2 receptor signaling in an experimental model of hepatic cardiomyopathy. Hepatology. 2020;71:1391\u2013407.","journal-title":"Hepatology"},{"key":"565_CR15","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","volume":"56","author":"M Rajesh","year":"2010","unstructured":"Rajesh M, Mukhopadhyay P, B\u00e1tkai S, Patel V, Saito K, Matsumoto S, Kashiwaya Y, Horv\u00e1th B, Mukhopadhyay B, Becker L, Hask\u00f3 G, Liaudet L, Wink DA, Veves A, Mechoulam R, Pacher P. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol. 2010;56:2115\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"565_CR16","doi-asserted-by":"publisher","first-page":"13958","DOI":"10.1038\/ncomms13958","volume":"8","author":"M Soethoudt","year":"2017","unstructured":"Soethoudt M, Grether U, Fingerle J, Grim TW, Fezza F, de Petrocellis L, Ullmer C, Rothenhausler B, Perret C, van Gils N, Finlay D, MacDonald C, Chicca A, Gens MD, Stuart J, de Vries H, Mastrangelo N, Xia L, Alachouzos G, Baggelaar MP, Martella A, Mock ED, Deng H, Heitman LH, Connor M, Di Marzo V, Gertsch J, Lichtman AH, Maccarrone M, Pacher P, Glass M, van der Stelt M. Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity. Nat Commun. 2017;8:13958.","journal-title":"Nat Commun"},{"key":"565_CR17","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/nprot.2008.138","volume":"3","author":"P Pacher","year":"2008","unstructured":"Pacher P, Nagayama T, Mukhopadhyay P, Batkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc. 2008;3:1422\u201334.","journal-title":"Nat Protoc"},{"key":"565_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.freeradbiomed.2019.11.027","volume":"152","author":"E Trojnar","year":"2020","unstructured":"Trojnar E, Erdelyi K, Matyas C, Zhao S, Paloczi J, Mukhopadhyay P, Varga ZV, Hasko G, Pacher P. Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome. Free Radic Biol Med. 2020;152:540\u201350.","journal-title":"Free Radic Biol Med"},{"key":"565_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.yjmcc.2013.05.009","volume":"62","author":"ZV Varga","year":"2013","unstructured":"Varga ZV, Kupai K, Szucs G, Gaspar R, Paloczi J, Farago N, Zvara A, Puskas LG, Razga Z, Tiszlavicz L, Bencsik P, Gorbe A, Csonka C, Ferdinandy P, Csont T. MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative\/nitrative stress and subsequent dysfunction in the heart. J Mol Cell Cardiol. 2013;62:111\u201321.","journal-title":"J Mol Cell Cardiol"},{"key":"565_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58:389\u2013462.","journal-title":"Pharmacol Rev"},{"key":"565_CR21","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.yjmcc.2009.10.025","volume":"48","author":"F Weis","year":"2010","unstructured":"Weis F, Beiras-Fernandez A, Sodian R, Kaczmarek I, Reichart B, Beiras A, Schelling G, Kreth S. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure. J Mol Cell Cardiol. 2010;48:1187\u201393.","journal-title":"J Mol Cell Cardiol"},{"key":"565_CR22","doi-asserted-by":"publisher","first-page":"H2210","DOI":"10.1152\/ajpheart.00688.2007","volume":"293","author":"M Rajesh","year":"2007","unstructured":"Rajesh M, Mukhopadhyay P, Batkai S, Hasko G, Liaudet L, Huffman JW, Csiszar A, Ungvari Z, Mackie K, Chatterjee S, Pacher P. CB2-receptor stimulation attenuates TNF-{alpha}-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am J Physiol Heart Circ Physiol. 2007;293:H2210-2218.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"565_CR23","doi-asserted-by":"publisher","first-page":"104578","DOI":"10.1016\/j.phrs.2019.104578","volume":"151","author":"ACM van Esbroeck","year":"2020","unstructured":"van Esbroeck ACM, Varga ZV, Di X, van Rooden EJ, Toth VE, Onodi Z, Kusmierczyk M, Leszek P, Ferdinandy P, Hankemeier T, van der Stelt M, Pacher P. Activity-based protein profiling of the human failing ischemic heart reveals alterations in hydrolase activities involving the endocannabinoid system. Pharmacol Res. 2020;151:104578.","journal-title":"Pharmacol Res"},{"key":"565_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","volume":"50","author":"P Pacher","year":"2011","unstructured":"Pacher P, Mechoulam R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res. 2011;50:193\u2013211.","journal-title":"Prog Lipid Res"},{"key":"565_CR25","doi-asserted-by":"crossref","unstructured":"Pacher P, Batkai S, Kunos G. Cardiovascular pharmacology of cannabinoids. Handb Exp Pharmacol. 2005;599\u2013625.","DOI":"10.1007\/3-540-26573-2_20"},{"key":"565_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.phrs.2009.04.003","volume":"60","author":"S Batkai","year":"2009","unstructured":"Batkai S, Pacher P. Endocannabinoids and cardiac contractile function: pathophysiological implications. Pharmacol Res. 2009;60:99\u2013106.","journal-title":"Pharmacol Res"},{"key":"565_CR27","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/febs.12260","volume":"280","author":"P Pacher","year":"2013","unstructured":"Pacher P, Kunos G. Modulating the endocannabinoid system in human health and disease \u2013 successes and failures. FEBS J. 2013;280:1918\u201343.","journal-title":"FEBS J"},{"key":"565_CR28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jcmg.2017.11.019","volume":"11","author":"I Valenta","year":"2018","unstructured":"Valenta I, Varga ZV, Valentine H, Cinar R, Horti A, Mathews WB, Dannals RF, Steele K, Kunos G, Wahl RL, Pomper MG, Wong DF, Pacher P, Schindler TH. Feasibility evaluation of myocardial cannabinoid type 1 receptor imaging in obesity: a Translational approach. JACC Cardiovasc Imaging. 2018;11:320\u201332.","journal-title":"JACC Cardiovasc Imaging"},{"key":"565_CR29","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jacc.2007.03.057","volume":"50","author":"P Mukhopadhyay","year":"2007","unstructured":"Mukhopadhyay P, Batkai S, Rajesh M, Czifra N, Harvey-White J, Hasko G, Zsengeller Z, Gerard NP, Liaudet L, Kunos G, Pacher P. Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity. J Am Coll Cardiol. 2007;50:528\u201336.","journal-title":"J Am Coll Cardiol"},{"key":"565_CR30","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/cvr\/cvp369","volume":"85","author":"P Mukhopadhyay","year":"2010","unstructured":"Mukhopadhyay P, Rajesh M, Batkai S, Patel V, Kashiwaya Y, Liaudet L, Evgenov OV, Mackie K, Hasko G, Pacher P. CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc Res. 2010;85:773\u201384.","journal-title":"Cardiovasc Res"},{"key":"565_CR31","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00125-011-2061-4","volume":"54","author":"AB El-Remessy","year":"2011","unstructured":"El-Remessy AB, Rajesh M, Mukhopadhyay P, Horvath B, Patel V, Al-Gayyar MM, Pillai BA, Pacher P. Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line. Diabetologia. 2011;54:1567\u201378.","journal-title":"Diabetologia"},{"key":"565_CR32","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1476-5381.2010.00712.x","volume":"160","author":"M Rajesh","year":"2010","unstructured":"Rajesh M, Mukhopadhyay P, Hasko G, Liaudet L, Mackie K, Pacher P. Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. Br J Pharmacol. 2010;160:688\u2013700.","journal-title":"Br J Pharmacol"},{"key":"565_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00395-010-0090-7","volume":"105","author":"V Tiyerili","year":"2010","unstructured":"Tiyerili V, Zimmer S, Jung S, Wassmann K, Naehle CP, Lutjohann D, Zimmer A, Nickenig G, Wassmann S. CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function. Basic Res Cardiol. 2010;105:465\u201377.","journal-title":"Basic Res Cardiol"},{"key":"565_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.108.811992","volume":"119","author":"K Sugamura","year":"2009","unstructured":"Sugamura K, Sugiyama S, Nozaki T, Matsuzawa Y, Izumiya Y, Miyata K, Nakayama M, Kaikita K, Obata T, Takeya M, Ogawa H. Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation. 2009;119:28\u201336.","journal-title":"Circulation"},{"key":"565_CR35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/cvr\/cvp339","volume":"84","author":"S Immenschuh","year":"2009","unstructured":"Immenschuh S. Endocannabinoid signalling as an anti-inflammatory therapeutic target in atherosclerosis: does it work? Cardiovasc Res. 2009;84:341\u20132.","journal-title":"Cardiovasc Res"},{"key":"565_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/ATVBAHA.108.168757","volume":"29","author":"F Dol-Gleizes","year":"2009","unstructured":"Dol-Gleizes F, Paumelle R, Visentin V, Mares AM, Desitter P, Hennuyer N, Gilde A, Staels B, Schaeffer P, Bono F. Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2009;29:12\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"565_CR37","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/bph.13226","volume":"173","author":"G Gruden","year":"2016","unstructured":"Gruden G, Barutta F, Kunos G, Pacher P. Role of the endocannabinoid system in diabetes and diabetic complications. Br J Pharmacol. 2016;173:1116\u201327.","journal-title":"Br J Pharmacol"},{"key":"565_CR38","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/dom.13150","volume":"20","author":"T Jourdan","year":"2018","unstructured":"Jourdan T, Park JK, Varga ZV, Paloczi J, Coffey NJ, Rosenberg AZ, Godlewski G, Cinar R, Mackie K, Pacher P, Kunos G. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy. Diabetes Obes Metab. 2018;20:698\u2013708.","journal-title":"Diabetes Obes Metab"},{"key":"565_CR39","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.2337\/db09-1336","volume":"59","author":"F Barutta","year":"2010","unstructured":"Barutta F, Corbelli A, Mastrocola R, Gambino R, Di Marzo V, Pinach S, Rastaldi MP, Perin PC, Gruden G. Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy. Diabetes. 2010;59:1046\u201354.","journal-title":"Diabetes"},{"key":"565_CR40","doi-asserted-by":"crossref","unstructured":"Westermann D, Van Linthout S, Dhayat S, Dhayat N, Schmidt A, Noutsias M, Song XY, Spillmann F, Riad A, Schultheiss HP and Tsch\u00c3\u00b6pe C. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Research in Cardiology. 2007;102:500\u20137.","DOI":"10.1007\/s00395-007-0673-0"},{"key":"565_CR41","doi-asserted-by":"crossref","unstructured":"Westermann D, Walther T, Savvatis K, Escher F, Sobirey M, Riad A, Bader M, Schultheiss H-P and Tsch\u00c3\u00b6pe C. Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy. Diabetes. 2009;58:1373\u201381.","DOI":"10.2337\/db08-0329"},{"key":"565_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccl.2013.09.015","volume":"32","author":"FL Johnson","year":"2014","unstructured":"Johnson FL. Pathophysiology and etiology of heart failure. Cardiol Clin. 2014;32:9\u201319.","journal-title":"Cardiol Clin"},{"key":"565_CR43","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.lfs.2012.10.028","volume":"92","author":"CH Mandavia","year":"2013","unstructured":"Mandavia CH, Aroor AR, DeMarco VG, Sowers JR. Molecular and metabolic mechanisms of cardiac dysfunction in diabetes. Life Sci. 2013;92:601\u20138.","journal-title":"Life Sci"},{"key":"565_CR44","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1096\/fj.09-129478","volume":"23","author":"N Defer","year":"2009","unstructured":"Defer N, Wan J, Souktani R, Escoubet B, Perier M, Caramelle P, Manin S, Deveaux V, Bourin M-C, Zimmer A, Lotersztajn S, Fo Pecker, Pavoine C. The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia\/reperfusion-induced cardiomyopathy. The FASEB Journal. 2009;23:2120\u201330.","journal-title":"The FASEB Journal"},{"key":"565_CR45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2008.12.040","volume":"205","author":"F Montecucco","year":"2009","unstructured":"Montecucco F, Matias I, Lenglet S, Petrosino S, Burger F, Pelli G, Braunersreuther V, Fo Mach, Steffens S, Di Marzo V. Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis. Atherosclerosis. 2009;205:433\u201341.","journal-title":"Atherosclerosis"},{"key":"565_CR46","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.yjmcc.2008.12.014","volume":"46","author":"F Montecucco","year":"2009","unstructured":"Montecucco F, Lenglet Sb, Braunersreuther V, Burger F, Pelli G, Bertolotto M, Mach FO, Steffens S. CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia\/reperfusion. J Mole Cell Cardiol. 2009;46:612\u201320.","journal-title":"J Mole Cell Cardiol"},{"key":"565_CR47","doi-asserted-by":"crossref","unstructured":"Hoyer FF, Steinmetz M, Zimmer S, Becker A, L\u00c3\u00bctjohann D, Buchalla R, Zimmer A and Nickenig G. Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo. J Mole Cel Cardiol. 2011;51:1007\u201314.","DOI":"10.1016\/j.yjmcc.2011.08.008"},{"key":"565_CR48","doi-asserted-by":"publisher","first-page":"H1064","DOI":"10.1152\/ajpheart.00444.2011","volume":"302","author":"F Molica","year":"2012","unstructured":"Molica F, Matter CM, Burger F, Pelli G, Lenglet S, Zimmer A, Pacher P, Steffens S. Cannabinoid receptor CB2 protects against balloon-induced neointima formation. Am J Physiol Heart Circ Physiol. 2012;302:H1064\u201374.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"565_CR49","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/eurheartj\/ehr449","volume":"33","author":"F Montecucco","year":"2012","unstructured":"Montecucco F, Di Marzo V, da Silva RF, Vuilleumier N, Capettini L, Lenglet SB, Pagano S, Piscitelli F, Quintao S, Bertolotto M, Pelli G, Galan K, Pilet L, Kuzmanovic K, Burger F, Pane B, Spinella G, Braunersreuther V, Gayet-Ageron AL, Pende A, Viviani GL, Palombo D, Dallegri F, Roux-Lombard P, Santos RAS, Stergiopulos N, Steffens S, Mach FO. The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. Eur Heart J. 2012;33:846\u201356.","journal-title":"Eur Heart J."},{"key":"565_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.coph.2006.01.001","volume":"6","author":"P Pacher","year":"2006","unstructured":"Pacher P, Szabo C. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr Opin Pharmacol. 2006;6:136\u201341.","journal-title":"Curr Opin Pharmacol"},{"key":"565_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315\u2013424.","journal-title":"Physiol Rev"},{"key":"565_CR52","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.2337\/db10-1809","volume":"60","author":"F Barutta","year":"2011","unstructured":"Barutta F, Piscitelli F, Pinach S, Bruno G, Gambino R, Rastaldi MP, Salvidio G, Di Marzo V, CavalloPerin P, Gruden G. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy. Diabetes. 2011;60:2386\u201396.","journal-title":"Diabetes"},{"key":"565_CR53","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ki.2014.165","volume":"86","author":"F Barutta","year":"2014","unstructured":"Barutta F, Grimaldi S, Franco I, Bellini S, Gambino R, Pinach S, Corbelli A, Bruno G, Rastaldi MP, Aveta T, Hirsch E, Di Marzo V, Gruden G. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice. Kidney Int. 2014;86:979\u201390.","journal-title":"Kidney Int"},{"key":"565_CR54","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.bbrc.2014.08.008","volume":"451","author":"P Mohnle","year":"2014","unstructured":"Mohnle P, Schutz SV, Schmidt M, Hinske C, Hubner M, Heyn J, Beiras-Fernandez A, Kreth S. MicroRNA-665 is involved in the regulation of the expression of the cardioprotective cannabinoid receptor CB2 in patients with severe heart failure. Biochem Biophys Res Commun. 2014;451:516\u201321.","journal-title":"Biochem Biophys Res Commun"}],"updated-by":[{"DOI":"10.1007\/s11357-022-00593-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000}}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-022-00565-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-022-00565-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-022-00565-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T21:18:05Z","timestamp":1666473485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-022-00565-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["565"],"URL":"https:\/\/doi.org\/10.1007\/s11357-022-00565-9","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11357-022-00593-5","asserted-by":"object"}]},"ISSN":["2509-2715","2509-2723"],"issn-type":[{"value":"2509-2715","type":"print"},{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,22]]},"assertion":[{"value":"23 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11357-022-00593-5","URL":"https:\/\/doi.org\/10.1007\/s11357-022-00593-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}